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QUid pro QUo, QUid VadiS
CONFLICT OF INTEREST POLICY OF LOMA LINDA UNIVERSITY
SCHOOL OF MEDICINE
San Bernardino:
A Case Study in
Environmental Justice
According to a recent state analysis, the
San Bernardino rail yards presents one of
the greatest cancer risks to nearby residents
of any rail yard in the State of California.
This was the perfect topic to cap off the
19th annual Contributor’s Convocation.
The case study in environmental justice
brought together the mayor of San
Bernardino, a leader of the Center for
Community Action and Environmental
Justice, a spokesperson of the Burlington
Northern Santa Fe railroad, and faculty of
Loma Linda University who are conducting
a study of 900 homes surrounding the rail
yard. The roundtable was chaired by Roy
Branson, director of the Center for
Christian Bioethics.

From left is Susanne Montgomery, PhD, MPH,
LLU School of Public Health; Tom Dolan, PhD,
Inland Congregations United for Change; Patrick
J. Morris, mayor of San Bernardino; Roy
Branson, PhD, moderator; Samuel Soret, PhD,
MPH, LLU School of Public Health; and David
Seep, Burlington Northern Santa Fe Railway
Company.

Richard E. Chinnock, MD, FAAP
Professor and chair of pediatrics
School of Medicine, Loma Linda University, Loma Linda, California
Chair, task force on industry and academia
ver the 2009–2010 school year, the
School of Medicine at Loma Linda
University invested a great deal of time and
effort developing and adopting a policy
regarding conflict of interest. The School
of Medicine adopted this policy to advance
the value of integrity integral to its declared
aim“to make man whole.” 1
The scope of the issue of conflict of
interest is large, with 95 percent of all
physicians reporting having had some
interaction with industry. And the estimated amount spent each year in the
United States is estimated at between $40
to $60 billion dollars.
Loma Linda University School of
Medicine (LLUSM), as a Seventh-day
Adventist Christian institution, has long
had a tradition of valuing ethical standards
and adhering to a strong ethos of mission
and service. There was, however, less consensus on campus regarding the necessity
and/or advisability of enacting a policy
aimed at oversight of physician relationships with industry. Comments received
during the process ranged from those who
believed that, as a Christian institution, we
were unlikely to have a problem with dis-
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reputable relationships, to those who
believed that a Christian institution should
embrace the most restrictive elements of
the debate.
In 2008, the Association of American
Medical Colleges (AAMC) released its
task force report on Industry Funding of
Medical Education. It was at this point that
most medical schools, Loma Linda
University included, began in earnest to
develop its own policies.
In order to mediate between these
competing interests and to address a
topic that was gaining increasing notice in
the academic world, in 2008 the dean of
the LLU School of Medicine appointed a
task force chair to develop a policy for the
school. This paper will describe the history of financial relationships between
industry and medical school academia,
and describe the conflicts of interest in an
academic health center. It will also
explore the scientific basis of influence
and reciprocity. And lastly, it will describe
the process of developing the policy and
the rationale for the components of the
Loma Linda University School of
Medicine “Vendor Policy.”
Please turn to page 2
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editorial
THANK YOU, MARK CARR—
WELCOME, ROY BRANSON!
Loma Linda University is proud that
the founding of the Center for Christian
Bioethics, in 1984, took place early in the
rise of bioethics in the United States. One
reason the center continues to make a contribution to the field is the continuity of its
leadership—three directors in the center’s
first 26 years: Dr. Jack Provonsha, a physician and theologian, who founded the center; Dr. David Larson, a theological
ethicist, whose 15 years as director saw
national conferences and the establishment of a significant endowment; and Dr.
Mark Carr, also a theological ethicist,
whose nine years at the helm have seen
several innovations.
This year, Dr. Carr decided to move
on from being director to devote more
time to writing in the field of ethics. I want
to celebrate Mark Carr’s years as director
and welcome the center’s new director,
Roy Branson, who has been involved in
bioethics since the beginnings of the field.
As director, Dr. Carr worked particularly closely with three schools to enrich
their ethics offerings. The center provided
office facilities for the executive director of
the American Society for Dental Ethics.

Historical context
pivotal event in American medicine
occurred in 1999 when a patient,
Jesse Gelsinger, died during a gene transfer
experiment. Controversy was provoked
when it was revealed that the principal
investigator for the trial also had ownership
interests in the company making the product. Prior to 1999, the number of articles in
the medical literature concerning conflicts
of interest between industry and medical
institutions averaged about 5 to 10 annually. After this point the number of journal
articles increased more than 10-fold.
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Dr. Carr helped design ethics courses for
the newly founded School of Pharmacy
and served on its admissions committee.
He also cooperated with the School of
Public Health in integrating ethics into a
national public health conference. While
Dr. Carr directed the MA degree in
bioethics, students enrolled in schools
across the campus also earned master’s
degrees in bioethics.
Dr. Carr hosted the center’s first-ever
Bioethics Summer Camp and started the
Claritas Essay Contest, which has drawn
many Loma Linda University undergraduate and graduate students into reading,
thinking, and writing about bioethics.
Under Dr. Carr’s leadership, the
Provonsha Lecture became a lecture series
with new, associated courses. He is editing
the lectures into printed volumes.
When Dr. Carr resigned as director,
Loma Linda University, in the spring of
2010, invited Dr. Branson to serve as permanent director. Dr. Branson has a rich
background in both teaching ethics and
fostering centers of writing and research.
He started the ethics program at the
Seventh-day Adventist Seminary at
Andrews University, where he introduced
the field to several of the ethics professors
at LLU. Soon after the Kennedy Institute
of Ethics was founded at Georgetown

University, Dr. Branson was invited to join
as a full-time senior research scholar.
Later, he started and directed the Center
for Law and Public Policy, affiliated with
Columbia Union College, until he joined
the LLU School of Religion as associate
dean, in 2008. Dr. Branson has already led
the center in presenting several wellattended roundtables on issues of
bioethics in the public square.
Continuing as associate director of
the center is Dr. Robert Orr, both a physician and ethicist. Dr. Orr directs the clinical ethics consultation service in the LLU
Medical Center and is training five physicians, who are fellows of the center, in the
field of clinical bioethics. His recent volume, Medical Ethics and the Faith Factor: A
Handbook for Clergy and Health-Care
Professionals, will be featured in the next
issue of UPDATE.
With its strong faculty of professors trained in ethics, Loma Linda
University continues its commitment to
being one of the country’s outstanding
centers of bioethics in the clinical and
health care settings.

Disclosure of financial relationships
between industry and physicians took a
new turn when the U.S. Department of
Justice agreed to a deal with orthopedic
device companies to disclose payments to
physicians on the Internet. (An entry on
The Wall Street Journal’s health blog cheekily asked, “Hey, orthopedic surgeons:
Check out how much your pals are making
in consulting fees from companies that sell
orthopedic implants.” 2
It is true that the history of financial
dealings between industry and academia
has had many success stories. For exam-

ple, Eli Lilly worked with researchers at
the University of Toronto to develop
insulin. However, concerns about undue
influence from drug manufacturers date
back at least 100 years. A review of the
Merck Manual from the early 1900s
noted that “although this book is gotten
out by a manufacturing firm and with
some view towards its advertising value, it
nonetheless is of such merit that it is
deserving of mention.” 3
A pivotal series of events occurred in
the 1940s when the American Medical
Association began marketing its physician

Jon Paulien, PhD
Chair, administrative committee
Center for Christian Bioethics

database information to the pharmaceutical industry. The pharmaceutical companies used the information to study the
effectiveness of various marketing techniques on physician prescribing patterns.
This led to the practice of pharmaceutical
representatives entering physicians’ offices
to provide clinical information related to
their products. Marketing practices
included providing free food and items
with company logos, such as pens, note
pads, etc.
In 1959, pharmaceutical company
marketing practices were the subject of a
U.S. Senate hearing led by Senator Estes
Kefauver. In 1981, in an attempt to promote research without an infusion of federal dollars, the U.S. government provided
tax credits to companies if they invested in
university-based basic research. In 1983, a
California state commission found that a
number of University of California faculty
had financial interests in companies funding their research.
The medical literature addressed these
issues in 1984 when The New England
Journal of Medicine announced a policy on
conflict of interest. Four years later, the
International Committee of Medical
Journal Editors (ICMJE) developed a
statement of requirements for authors
regarding financial disclosure. In 1993,
Minnesota was the first state to limit drug
company gifts.
Organized medicine joined the discussion in 1990, when the Association of
American Medical Colleges (AAMC), the
American Medical Association (AMA),
and the American College of Physicians
(ACP) all published guidelines and position papers regarding conflicts of interest
and gifts to physicians.

What is a conflict of interest?
conflict of interest is defined as a set
of circumstances that creates a risk
that professional judgment or actions
regarding a primary interest will be unduly
influenced by a secondary interest. Primary

A

interests are those elements of first importance, such as the welfare of patients,
integrity of research, and quality of education. Secondary interests are issues such as
financial gain, professional advancement or
recognition, personal achievement, and
favors to family or friends. Secondary
interests are not inherently unethical. But
when a secondary interest has inappropriate weight in a decision and distorts the
pursuit of a primary interest, it exerts
undue influence.
Conflicts of interest can be dealt with
in various ways. There is disclosure, prohibition, and“management” of the conflict of
interest. Most conflicts of interest in the
academic setting have historically been
handled by disclosure agreements. More
recently, prohibition has been used more
aggressively.
In developing conflict of interest
policies, the following factors must be
considered.
Proportionality: Is the policy efficiently directed at the most important conflicts?
Transparency: Is the policy comprehensible and accessible to the individuals and institutions that may be
affected?
Accountability: Does the policy indicate who is responsible for enforcing
and revising it?
Fairness: Does the policy apply
equally to all relevant groups within
an institution?
Arguments against conflict of interest
policies have come from both sides of the
ideological spectrum. There are those who
believe that policies have become too strict.
They worry that financial disclosure invites
ad hominem attacks, shifts focus away
from the merits of work to the biography
of the author, and develops a new
“Scientific McCarthyism” wherein research
is tainted merely by association with industry. Those who believe that the new policies are too lax note that the policies are
weak and inconsistent and that they are

inadequately administered and enforced.
Most tellingly, there have been few, if any,
studies evaluating the implementation or
effectiveness of conflict of interest policies.
The core principles of professionalism
are autonomy, objectivity, and altruism.
And there is an expectation that medical
professionals can behave in the best interests of their patients regardless of any
financial or other beneficial relationship
with industry. But some are concerned that
there is a “bias of rationality.” David
Blumenthal from Mass General Hospital

“the core principles of
professionalism are
autonomy, objectivity,
and altruism…but some
are concerned that there
is a ‘bias of rationality.’”

in Boston states, “Doctors don’t want to
hear that there are things going on in their
heads that they are not aware of.” 4 A recent
editorial in a medical journal more pithily
put it as,“Your soul for a pen?” 5 Are physicians influenced by being given trinkets, by
support for medical education, by provision of drug samples, and by consulting
relationships with industry?
Every time a physician sees a patient,
except in free clinic situations, there is a
financial transaction that takes place. A
charge is generated and a payment is
received for services.There has always been
the concern that a physician could be more
interested in the payment than in the
patient. Indeed, the Hippocratic Oath
states in part that a physician should prescribe regimens for the good of his patients
according to his ability and judgment and
never to do harm to anyone. The LLUSM
Please turn to page 4

Update • Volume 22, Issue 3 • Page 3

Physician’s Oath states that “the wholeness
of my patient will be my first consideration.”
It is understood that physicians should be
appropriately compensated for the services,
but this should never overshadow his or her
responsibility to the patient.

llUSM conflict of interest
basic principles
he LLUSM policy provides guidance
for gifts and compensation, drug
samples, drug detailing activities, educational and other professional activities, disclosure, and logistics of the policy.
Disclosure: Justice Louis Brandeis
(1914) noted that“Sunshine is said to be the
best of disinfectants.” 6 But there is a growing
concern that though disclosure is an essential
element of conflict of interest policies, it is
probably an insufficient element.

T

“ disclosure
relies on the
honesty of the
d i s c l o s e r.”

The first challenge for disclosure
policies is that there is not a sufficient
policing process. In a study of articles on
coronary artery stents, it was noted that
of 75 authors who disclosed as least one
potential conflicting relationship, only
two authors disclosed their relationship
in every article that they published.7
Disclosure relies on the honesty of the
discloser. There have been several reports
regarding well-regarded scientists who
failed to disclose hidden payments from
pharmaceutical companies.8 In addition,
disclosure does not resolve conflicts of
interest, but rather places the onus for
evaluation on the person receiving the
disclosure. For example, disclosure of
possible conflicts of interest in patient
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research has been shown to not have a
significant effect. And it may be counterproductive if the investigators who have
disclosed their conflict of interest, believe
that they can be more aggressive in promoting a therapy. 9
Disclosure does not deal with the
unconscious biases involved in human relationships. I know that I have come to
doubt my ability to evaluate those actors or
agencies that seek to influence me. Indeed,
most physicians are subject to the “Lake
Wobegon Effect.” In his semi-mythical
hometown of Lake Wobegon, Garrison
Keillor reports that “all the children are
above average.” Similarly, a study of
Swedish drivers reports that 90 percent of
them believe that they are better drivers
than the average. 10 Most physicians claim
that marketing and “trivial” gifts do not
influence them. But, most physicians
believe that the same tactics work on the
majority of other physicians.
Influence: Let me describe the challenges of influence by referring to several
experiments. Influence is described as “a
power affecting a person, thing, or course of
events, especially one that operates without
any direct or apparent effect.” And reciprocity is the “quality of state of being reciprocal; mutual dependence, action, or
influence.” 11 The subconscious effects can
be seen in many different ways. We miss
what we aren’t looking for, and we are influenced by financial sponsorships. Even honest persons will sometimes behave
unethically (at least up to a point). Wellintended persons will give themselves some
“wiggle room.”
In a classic 1979 study, Ulric Neisser
showed a video clip to study subjects. Two
teams of players were passing a basketball
back and forth. The subjects were asked to
count the number of passes made by the
team dressed in black. About two-thirds of
the way through the clip, a woman with an
umbrella unexpectedly walks through the
teams. Only 21 percent of the videowatching subjects noted the woman. In

other words, many don’t see what they are
not expecting to see.12
In a study that evaluated the influence
of fictional sponsors, study subjects in a
functional MRI (fMRI) were shown paintings and asked to rate them. The investigators were able to correlate brain responses
with the subjects’ ratings of paintings. Then
the subjects were informed that a (fictional)
company had sponsored the research and
provided a cash reimbursement to the
experimental subject. Prior to the next
phase of the test the subjects were shown
the company’s logo, which subsequently
appeared randomly near paintings. The
mere presence of the sponsoring logo near a
painting changed the subject’s passive brain
fMRI response and led to the subject’s more
positive rating of the painting. We are subconsciously influenced by incentives.13
Honesty: In a test of honesty,
researchers devised a test of general knowledge. Students were told that they would
receive a certain amount of money for each
correct response. The first group of students marked their test sheet with their
answers, then transferred the answers to a
second answer sheet, and turned both
sheets in to the investigator. The second
group of students was given an answer
sheet with the correct answer in grey. They
could choose to transfer their own answer
or choose to change their answer to the
correct answer, and then turned in both
sheets to the investigator. There was the
possibility that their deception would be
found out.The third group of students was
given the answer sheet with the correct
answers in grey, but this time they were
allowed to shred their original answer
sheet, eliminating the ability of the investigator to determine if they were cheating. A
separate fourth group of students was
asked to predict how much cheating in this
last group there would be.
Surprisingly, the amount of cheating
that occurred was significantly less than
predicted. The amount of cheating was
very similar between the second and third

groups. It has been posited that the students cheated less than the maximum
amount they may have gotten away with in
order to maintain their self-concept that
they were basically honest. They would
thereby avoid receiving a negative self-signal. In other words, they would cheat, but
“just a little.” When the same experiment
was conducted using tokens rather than
cash, the amount of cheating doubled. A
non-cash “gift” increases the likelihood of
unethical behavior.14
Another experiment evaluated
unconscious influences. Two groups of
study subjects were told to place a drop of
saliva on a test strip. The first group was
told that a change of color of the strip
showed the presence of disease. The second group was told that a change of color
showed the absence of disease. The second
group waited twice as long to see whether
the strip would change color. The implication is that we work hardest for what we
want to see.15
In a money-sharing game between
two players, one player was designated as
the “dictator.” This player was given the
option of giving $6 to himself and $1 to the
“other,” or the option of giving $5 to himself
and $5 to the other. The dictator made the
altruistic distribution of the money in 74
percent of cases. In the next phase of this
experiment the amount given to the other
was randomly assigned at $1 or $5. That is,
if the dictator received $6 the other could
receive $1 or $5. If the dictator received $5,
the other could receive either $1 or $5. The
dictator was given the option to see the
randomization result before deciding on
the distribution. Surprisingly, only 44 percent of the dictators chose to see the results
beforehand, depriving themselves of the
opportunity to choose the fairest option.
And, in this scenario only 38 percent of the
others received $5. The implication is that
people are good at not looking when they
don’t want to see.16
Biases: Let’s look at self-serving biases.
In a study of work effort versus work

reward, subjects were asked to complete
the task of filling out surveys. They were
then given money and an envelope to pay
themselves and another “employee” who
had already left. The subjects were told one
of four different scenarios. The scenarios
and how the subjects allocated the money
is as follows. When the other “employee”
worked half as much time and filled out half
as many surveys, study subjects allocated
the money in the expected 2/3 to themselves and 1/3 to the other “employee” —a
simple merit principle. When told that the
“employee” had worked half as much time
but completed twice as many surveys or
that the other“employee” had worked twice
as much time but had completed half as
many surveys the study subjects allocated
60 percent of the money to themselves and
40 percent to the other “employee.” The
experiment results illustrate a merit principle that advantaged the study subject,
whether they had spent twice as much time
or completed twice as many surveys.
In the last scenario, the other
“employee” worked twice as much time and
completed twice as many surveys. This is
the reverse of the first scenario. However,
this time the study subject allocated 50
percent of the money to themselves and 50
percent to the other employee, presumably
because both had worked and therefore
both should be paid the same—an equal
division principle. Interestingly, nearly all of
the study subjects actually sent money via
mail to the other “employee.” However,
when free to choose among competing
principles of fair behavior, they tended to
gravitate toward those principles that most
favored their own interests.17
Other experiments reveal how people
apply different standards when evaluating a
proposition they wish to be true. To an
agreeable proposition people ask, “Can I
believe this?” To a disagreeable proposition
people respond, “Must I believe this?” For
example, a physician may evaluate evidence
that a particular treatment is effective. If
that physician stands to gain financially by

prescribing that treatment, the motivation
of financial gain may make the physician
more likely to regard the drug as effective.
Teaching someone the concept of the
“blind
spot” helps them to recognize it
bias
in others but not necessarily in themselves.
We“know” that we aren’t biased. However,
in others whose thoughts we do not know,
we can believe that they are biased. The
bias blind spot may explain why there are
such strong disagreements about whether
conflicts of interest are problematic.

“Some fairly egregious
examples of unethical
behavior have taken
place within medical
education.”
Awareness: Finally, there is the
effect of increasing awareness of moral
standards. A study divided students into
two groups. The first group was asked,
just prior to the exam, to recall 10 books
from high school. The second group was
asked to recall as many of the 10 commandments as they could. No one asked
about the 10 commandments cheated.
Some among those asked to recall high
school books did cheat. The researchers
concluded that the mere fact of having a
policy regarding conflicts of interest
might decrease questionable behavior. 18

loma linda University School
of Medicine conflict of interest
policy—specific requirements
e began the process of developing a policy at LLUSM with
these values in mind: the process should
be transparent, inclusive, and deliberative. The following is the timeline and
tasks accomplished in developing the
policy (Table 1.)

W

Please turn to page 6

Update • Volume 22, Issue 3 • Page 5

FOR

accept gifts from industry. However, an
unrestricted educational grant may be
given to a department or division.
Individuals with a conflict of interest may
not participate in institutional purchasing
decisions. Faculty and trainees may not
accept payment for attending an educational event, and industry may not supply
food to LLUSM events.

TABLE 1: DEVELOPMENT OF CONFLICT OF INTEREST POLICY
LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE—A CHRONOLOGY

6/07

Initial meeting with Dr. Hadley, dean, School of Medicine (SOM)

2/08

Dean appoints task force chair

6/08

Association of American Medical Colleges (AAMC) releases report

9/08

General call for volunteers from SOM faculty

9/08

Dissemination of AAMC, Pharmaceutical Research and Manufacturers of
America (PhRMA) information, and presentation to School of Medicine
executive committee (SMEC)

1/09

First meeting of task force (TF)
•Discusses comparisons between AAMC, PhRMA and Riverside
County Regional Medical Center (RCRMC) policies; examples
of policies from UCLA, Stanford, University of Pittsburgh

1/09

Presentation to Clinical Science Faculty Advisory Council (CSFAC)

2/09

Second meeting of task force
• Discussion of feedback regarding comparisons

3/09

Third meeting of task force
• Discussion of proposed policy

3/09

Proposed policy is disseminated to entire SOM faculty for review and
comment

5/09

Fourth meeting of task force
• Finalization of policy (again using ARS)

6/09

To general counsel for review

7/09

Response to general counsel review

7/09

Policy presented to CSFAC for review and comment

9/09

Final approval by MSEC and then to LLU Board of Trustees
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drug samples
The rationale for providing drug
samples is that short-term use allows for
assessment of potential side effects and
benefits before prescribing a full course.
And they can provide access to meds for
low-income patients.
However, many problems have been
documented.A large majority of drug samples are given to insured patients.
Physicians, their patients, and staff often
use the samples, even if they may not be the
best choice for a particular condition. Poor
patients may not be able to afford the follow-on course of a newer, non-generic
medication. Accordingly, the LLUSM policy states that samples are discouraged. If
samples are to be given, then they must be
logged, used solely to enhance patient care,
and not merely for convenience. No samples are to be used by faculty, staff, trainees,
or their families.
drug detailing
A pharmaceutical representative
engages in drug detailing when the representative provides information to a physician about particular medications. Drug
detailing is a $20 billion a year business
practice. While drug detailing can be a
valuable information service, it inevitably
co-mingles information with gifts from a
drug company to a physician; also, trainees
may not be able to discern information
from hype.
Accordingly, the LLUSM policy
states that drug company representatives
may have access to physicians only by
appointment. They are not permitted in a
patient care area except to provide in-service training or to demonstrate use (e.g. of
a blood sugar monitor) for patients. A faculty member must be present whenever a
pharmaceutical representative is interacting with a trainee. Faculty must thoroughly
vet any device training program. Indeed,
the overall activity of industry representatives is subject to oversight by faculty leaders, as well as the LLU hospital and Loma

drj 4k 3.11

Gifts and compensation
The AMA policy on gifts notes that it
is the responsibility of the individual physician to minimize conflicts of interest. Gifts
should be of minimal value, should benefit
patients, or should relate to a physician’s
work (e.g. pens, notepads). Faculty and
physician trainees (either post-graduate or
medical students) at LLUMC may not

Linda University Adventist Health
Sciences Center (LLUAHSC).
educational and other
professional activities
There are many opportunities for conflict of interest in not only the formal medical education curriculum, but also in the
informal or hidden curriculum (the attitudes and behaviors modeled by faculty).
Academic medical centers are increasingly dependent on industry support for
education. One half of physician continuing medical education is paid for by industry. Medical students are masters at delayed
gratification and finish medical school with
average indebtedness of $150,000. It is
unfortunate, but probably not unexpected,
that when queried, 80 percent of medical
students believe that they are entitled to
gifts from industry. It is for these and similar reasons that academic medical centers
have been targeted to be the vanguard of
the conflict of interest culture change in
medicine.
Some fairly egregious examples of
unethical behavior have taken place within
medical education. In 2004, the drug company Warner Lambert was fined $430 million for paying doctors unreasonable fees to
attend “consultant” meetings, for sponsoring expensive dinners to discuss off-label
uses of their drugs, and for planting people
in audiences to ask questions highlighting
benefits of their drugs. In 2007, Orphan
Medical was fined $20M for paying exorbitant speaker’s fees to promote their product. And in 2008, Merck was fined $58M
for company use of ghostwriters and for
non-disclosure of company ties to speakers
at medical meetings. A 1998 study found
that 13 percent of journal articles had been
ghostwritten (that is, an article written by
an industry writer would then have a faculty person’s name assigned to it as the
author).19
Speakers’ bureaus provide speakers
free of charge to educational institutions.
The lecturers receive honoraria and

expenses, paid by a drug company. In and
of itself, this practice may not be a problem.
But an ongoing payment over a number of
years creates the risk of undue influence.
Also, a company may exert substantial control over content by: 1. providing slides and
answers to questions; 2. insisting that a
presenter avoid mentioning a competitor’s
product; and 3. providing answers to possible questions raised about the drug.
With the foregoing considerations
in mind, the LLUSM policy on industry
support for education proscribes direct
interaction between industry and
trainees. The department chair must
determine educational merit for all educational programs and must have sole
discretion to determine how any funds
provided by industry are used. There
must not be an implicit or explicit quid
pro quo. All continuing medical education (CME) events must comply with
Accrediting Council for Continuing
Medical Education (ACCME) standards
for commercial support. This applies
whether the educational program is onor off-campus. Any educational activities
must be administered by departments
and not by individual faculty. Finally,
industry may not directly provide meals
either on- or off-campus.
LLUSM acknowledges that speakers’ bureaus may be just an arm of the
marketing department of the commercial
sponsor, and therefore are discouraged.
Any compensation provided to a faculty
member involved in speakers’ bureaus
must be at fair market value, the source of
compensation fully disclosed by the meeting sponsor, and the content of the lecture
solely the responsibility of the lecturer.
The lecture must be fair and balanced,
and the slides and educational materials
must be prepared by the lecturer. The
meeting organizer must be free from
influence by industry. The lecturer must
also make sure that the content reflects his
or her view, and not necessarily that of
LLUSM or any other LLUAHSC entity.

Consulting
LLUSM recognizes that an LLUSM
faculty member’s special knowledge and
expertise may be invaluable in developing
new products. But consulting arrange-

“there are many
opportunities for conflict
of interest…academic
medical centers are
increasingly dependent
on industry support for
education.”

ments cannot be gifts in disguise.
Compensation must be at fair market
value, paid through the employing corporation for specific tasks.

Conclusion
uring the last several years, the academic health center community has
increasingly debated the proper relationship
between academia and the health industry.
Collaborative and productive relationships
between academia and industry have provided numerous advances in health and the
treatment of disease. Simultaneously, an
intertwining of finances between academia
and industry has created the potential for
physicians to regard financial gain as the primary interest, rather than serving the best
interests of the patient. In some cases, physicians have stepped over the line. Loma
Linda University School of Medicine has
developed a policy that attempts to keep
those relationships that benefit the patient,
while eliminating those that create conflicts
of interest. There is still more work to be
done. Other schools within the university
will need to address their own unique considerations with this issue. There will need
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to be ongoing education of faculty and
physician trainees. Further work needs to be
done to “operationalize” the policy and to
determine consequences for non-adherence.
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HealtH Care: BUSineSS or SerViCe?
Mark Warren, School of Medicine, Loma Linda University
ealth care is arguably the most
important domestic issue that the
United States is facing in this blustering
economy. A major political platform for
both democrats and republicans alike, the
health care debate has inspired heated controversy, artistic expression, a global search
for answers, and most importantly, some
difficult questions about the core values of
American citizens.
The topic for this paper is ethically
charged and invigorated by true stories and
horrifying facts. In a tumult of political
opinions and the quagmire of a broken
health care system, the central ethical question emerges: is health care a basic human
right? If not, then the question of whether
health care is a business or a service is simply academic. But if, in fact, health care is a
right, then it becomes a discussion not simply about economics but about values. It
becomes a matter of urgent domestic and
global priority and ultimately a discussion
about what it means to apply a Christian
worldview to this pressing issue.

H

In The Pearl, John Steinbeck weaves
the tale of Kino, the indigent pearl diver,
his wife Juana, and their newborn son
Coyotito. When Coyotito is stung by a
scorpion, Kino and Juana take him to visit
the local doctor. At the gate of the wealthy
doctor, Kino pleads with a servant for an
audience with the physician. In anger, the
doctor replies to the servant turned intercessor,“Has he any money? No, they never
have any money. I, I alone in the world am
supposed to work for nothing—and I am
tired of it. See if he has any money.” When
Kino predictably produces nothing of any
value, he is left with his sick child, tormented by his own inferiority and shame
to find his own desperate way.1
Kino’s experience is fictional in this
context, but in the broader context of modern medicine, at least in the United States,
his story is frighteningly true. As citizens of
the world’s most powerful nation, we rub
shoulders with 46.3 million Kinos everyday within our own borders.2 The circumstances vary, but they are linked by a shared

obstacle. The business of medicine has
become exclusive and you cannot participate unless you can pay. Studies show that
some 20,000 Americans die for lack of
access to adequate health care each year.3
Further, it is estimated that 700,000
Americans face bankruptcy every year due
to medical bills.4 Add to this the fact that
no other nation on the planet burns
through a larger percentage of GDP on
health care and it is not difficult to see that
something is wrong.5
In most places in the United States,
health care is a business. At Loma Linda,
we have conspicuous and shining examples
of clinics that are primarily service oriented. Take the SACHS clinic system for
instance.6 And there are others, pockets all
over the United States where medicine is
more service than business. Not only in the
United States but abroad, there are organizations actively answering the primary ethical question. But on the whole, in the
United States, medicine is primarily a busiPlease turn to page 10
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ness. As a business there are many advantages. High-tech innovations and life-saving novel medications are all
market-driven. Without monetary incentive, some argue that cutting-edge research
and development would be unlikely, if not
impossible. Capitalism drives creativity and
excellence. But there can be a downside to
the business of medicine.
In a free market economy, there are
going to be inequalities. And if a society
chooses to uphold a free market economy,
it must decide which inequalities it is willing to tolerate. While the practice of hightech medicine in the free market
undoubtedly drives innovation, it may also
come to represent a dangerous conflict of
interest. The introduction of powerful,
profit-driven third-party payers has come
to represent, in many cases, a monolithic
business enterprise standing between

“the achilles heel of the
free market system…is
that it leaves millions
without access to the
very innovations…that it
inspires.”
patient and provider. The Achilles heel of
the free market system, when it comes to
health care, is that it leaves millions without access to the very innovations and lifesaving medications and procedures that it
inspires.
Insurance companies notoriously
avoid “adverse selection” of customers by
hiring experts to review applications, deny
coverage to risky investments, and at times
cancel coverage that might interfere with
the bottom line. Business is business. In
order to secure and keep coverage, customers often have to wade through the
quagmire of pre-existing conditions, of
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rescission, of denied claims, and of cessation of coverage upon employment change.
Some, not finding a provider willing to
accept them, are forced to hide assets or
spend down to be considered for Medicaid.
T.R. Reid, in The Healing of America,
argues that the health care debate is often
simply a financial debate. Since our
national identity is strictly tied to our primarily free market economy, any discussion
of universal access to health care is wildly
rhetorized as socialism. However, the heart
of the issue, he maintains, is the central
question we have identified. He offers this:
Should society guarantee health care,
the way we guarantee the right to
think and pray as you like, to get an
education, to vote in free elections?
Or is medicine a commodity to be
bought and sold, a product like a car,
a computer, or a camera? This is the
key question facing any nation as it
designs a health care system […]7
Citing Professor William Hsiao, the
Harvard economist who has “helped
design health care systems for more than a
dozen nations,”8 he goes on:
‘Before you can set up a health care
system for any country,’ Hsiao told
me, ‘you have to know that country’s
basic ethical values. The first question is: Do people in your country
have a right to health care? If the
people believe that medical care is a
basic right, you design a system that
means anybody who is sick can see a
doctor. If a society considers medical
care to be an economic commodity,
then you set up a system that distributes health care based on the ability
to pay. And then the poor, pretty
much, are left out.’9
So then, as Reid and Hsiao argue, the
central question in the health care policy
for any developed nation with a means to
provide for its citizens is an ethical one.
Arguments about market-based vs. government-based solutions are secondary.
Some argue very powerfully that a
nation that allows access to every one of

its citizens does so at the expense of quality of care, patient preference, innovative
excellence, and over-involvement of the
government in the form of taxation and
regulation. Informed by our political isolation, our perceived superiority, and our
pervasive individualistic culture, it is very
easy for us as Americans to dismiss universal access to health care as a threat to
our national identity. Unwilling to look
around the world, and more importantly
to realize that the socialism many fear in
health care has already been here for
decades, we fail to address seriously the
fundamental ethical question.10 While it is
beyond the scope of this paper to deal
with a comparative analysis of world
health care systems, it is worth noting that
every wealthy nation has both raised and
answered the central ethical question. All
wealthy nations have decided that every
one of their citizens deserves, as a matter
of basic human right, access to health care.
All that is, except the United States.
As Christians, whose worldview is
central to ethical considerations, the principles surrounding the health care issue gain
even more clarity. When it comes to health
care access, both domestically and abroad,
it is the women, the children, and the
downtrodden who are marginalized. The
message of Christ has undeniable social
implications and imposes unequivocal
responsibilities. Christ clearly asserted that
the central issue in authentic Christianity is
our treatment of those he refers to intimately as “the least of these my brethren.”
Conspicuous among those are the sick.11
Tracy Kidder, speaking of Paul Farmer, a
physician made famous by his dedication
to the underserved, offers this: “He’s still
going to make these hikes, he’d [Farmer]
insist, because if you say that seven hours is
too long to walk for two families of
patients, you’re saying that their lives matter less than some other’s, and the idea that
some lives matter less is the root of all that’s
wrong with the world.”12
So as we face a broken U.S. health

care system with its tragic inequities, the
central ethical question needs to be
addressed. If we fail to address the question
of health care as a basic human right, we
will be unprepared to confront the urgent
global priority of our world’s deplorable
inequities. But if we have the courage to
answer this call to moral responsibility,
regardless of its implications on the business of medicine, we will find that we are
doing exactly what Jesus asked us to do,
and we will redefine modern medicine, not
as a business, but as a service.
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SerViCe or BUSineSS?
Sidney E. Irving, School of Nursing, Loma Linda University
oday, health care lies at the forefront
of modern debate in the United
States. No one disagrees that reform is necessary; rather the issue is how the reform
should be structured. The question of
whether health care is a business or a service appears to be at the root of this debate.
As a newly licensed registered nurse, I
firmly believe that health care is a service.
What exactly does service mean?
According to the Oxford Dictionary, service is“the organized system of providing
labor, equipment, etc., to meet a public
need such as health” (2002, p. 2768). It is
the idea that one does something to help
others without making a profit. Business
lies on the other end of the spectrum. A
business, according to Oxford, is a commercial transaction (2002, p. 313).
Health care in this view implies that the
investors or owners will make a profit.
Our current health care system is run
as a business, although it has not always
been this way. Hippocrates, the father of
medicine, proclaimed in his famous oath,
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“do no harm.” Then, in the Dark and
Middle Ages, monks and nuns were the
main providers of health care. This tradition of religious organizations providing
health care is alive today (The History of
Health Care, 2008). In the United States,
especially during the Great Depression,
there were rural doctors who provided a
service to their community.
In the late 1940s, President
Truman advocated universal health care.
The American Medical Association
(AMA) was a powerful opponent to his
idea. Additionally, citizens felt this proposal was akin to communism and it was
dropped (Barlett & Steele, 2004). Then,
in 1965, Medicare and Medicaid were
created to assist the elderly and povertystricken to receive health care. At that
time, Americans had a sense of solidarity
that allowed them to use the government
to do something for the common good
(In It Together, 2009).
In the 1980s, under President
Reagan, there was a move from a non-

profit to a profit-based system of health
care, transforming health care from our
historical service model into a business
model. Reagan and his supporters firmly
believed in the market economy.
Competition, as well as supply and
demand ruled our health care arena. It was
believed that this change would lower
costs, while improving the quality of care.
In fact, today we spend more on
health care than any other nation. There
has been a rapid increase in our spending, with no increase in value or quality.
When I was a student at Cabrillo
College, a fellow student fell ill. He was
an athletic 19-year-old with cardiomyopathy and desperately in need of a heart
transplant. Fundraisers were conducted
to pay for his medical bills. Sadly, he is
not an anomaly. There are families that
have gone bankrupt because of their
medical bills. In the business model, the
health company shareholders and insurance companies are the ones who profit.
Please turn to page 12
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A market economy and health care
do not mix. We must not rely on a decentralized market process to produce an
efficient and equitable allocation of
health care at the individual level (Baily,
2004). We know this does not work. The
U.S. Census Bureau reported that, in
2008, there were 47 million Americans
with no health insurance. Eight in ten
uninsured people came from working
families (Facts about health care, health
insurance coverage, 2009). This number
appears to be on the rise.
President Obama is working to
change this situation. He believes that,
simply on the basis that we are all human,
we are obliged to give access to health care
to all Americans. Other countries believe
health care is a human right, while
Americans have categorized it as a consumer item (In it together, 2009).
In a market economy, competition
and free choice rule. However when
most people become ill, they are unable
to exercise free choice. The doctor that
they see, or do not see, will depend on
their health care insurance or lack
thereof. When a patient in California
gets cancer and wants to go to a specialty
hospital in a different state, the patients’
finances, as well as his insurance, will
make the choice for him. Besides insurance
companies, there is government regulation
that limits competition. Due to the Office
of Statewide Health Planning and
Development (OSHPD) regulations, it is
more expensive to build a hospital in
California than in other states.
There are those that argue this type of
regulation is stopping the market from
working properly. The purported need for
governmental oversight and regulation
clashes with the individual patient’s demand
for greater privacy and freedom of choice
(Johnson, 2006). Health care should be a
free market entity.If the market is allowed to
work properly, it will lead to innovation, better products,and decreased costs.It is a matter of getting the government less involved in

Page 12 • Update • Volume 22, Issue 3

health care, which will reduce waste and
remove inefficiencies.
In our capitalist economy, we have
the best health care system in the world;
top-notch equipment, well-trained doctors, highly skilled technicians. Health
care is provided for those that live in
poverty through Medicaid, while
Medicare is available for senior citizens.
As it is a limited resource, health care
should be allocated in the most efficient
way possible, with supply and demand as
the ruling force. According to Victor
Fuchs (as cited in Johnson 2006), it is economically impossible to give every person
in need of medical care all the treatment
that would be of potential benefit to him
or her. As health care is not a service, we

“ Health care is
not a consumer
item where we
want to increase
s a l e s .”
must seek the financial viability of hospitals and health care institutions.
According to Porter & Teisberg
(2004), competition is the root of the
problem in our health care system.
However, they believe competition is also
the solution. They advocate continuing
with our model of health care as a business, but with some important changes.
Today, there exists a practice of cost-shifting rather than reduction leading to a zero
increase in net value. Competition should
exist in the prevention, diagnosis, and
treatment of individual conditions or comorbidities, instead of among health plans,
networks, and hospitals. There is no rationale for the discounts given to large businesses for health care. It costs the same to
treat someone employed by the school dis-

trict as it does to treat a self-employed
lawyer. This is a cost-shifting measure that
limits competition.
Competition should be allowed on a
national level. Medicare reimbursement
costs vary depending on the treatment
location. Yet, according to studies by
Dartmouth Medical School (as cited by
Porter & Teisberg, 2004), “higher costs
are not associated with better medical
outcomes and cannot be explained by differences in age, sex, race, rates of illness, or
cost of living.” According to Porter and
Teisberg (2004), if true competition is
allowed, a business model would work
well for health care.
I believe, however, that health care as a
service is the model we should adopt. The
American health care system is stuck in
Piaget’s egocentric mode: as long as I have
health care, that’s all that matters. Under
today’s business model, we provide the best
health care, but only for a few Americans.
Competition simply doesn’t work. Health
care is not a consumer item where we want
to increase sales.
A focus on preventive care would
decrease overall health care costs.
Currently, most people have little or no
access to preventive care. They are unable
to get an early diagnosis of their disease,
increasing the cost to treat it. Money is also
spent on unnecessary emergency department visits. These scenarios exclude the
cost to society for letting our fellow
humans suffer.
The utilitarian theory guides us to
consider the consequences of our actions. If
health care is a service, more Americans
will receive health care. Fewer citizens will
experience hardships related to a lack of
coverage. Under the business model, society ends up paying more monetarily, and in
human costs, by not providing health care.
Regardless of the cost, the deontological view states that it is our duty as
humans to help others. The consequences
are not important, yet it is intrinsically
right to provide health care. Virtue theory

also supports health care as a service. This
theory states that one should do good in
this world. It would be difficult for most to
live well while others are needlessly suffering because they lack access to health care.
With the recent health care debates,
Obama has challenged our tradition of
individualism; we need to be able “to stand
in other people’s shoes” (In it together,
2009). We must adopt or listen to the
standpoint of the most marginalized and
vulnerable persons involved: the uninsured
and underinsured. These people are unable
to purchase health care or adequate health
care. As a society, we should provide this
service.
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2009 ContriBUtor’S ConVoCation: a neW VieW
he 2009 Center for Christian
Bioethics Contributors Convocation
took full advantage of the new Centennial
Complex.Roy Branson,PhD,director of the
Center for Christian Bioethics, began the
convocation by inviting Gerald Winslow,
PhD, vice president for spiritual life and
wholeness, LLUAHSC, and Robert Orr,
MD, associate director, Center for Christian
Bioethics, to provide an overview of clinical
ethics in the United States and at LLU.
With the return of Dr. Orr to the position of associate director of the center,
weekly case conferences have returned as
well. In addition, Dr. Orr has instituted, in
cooperation with Loma Linda University
Medical Center, an ethics fellows program
designed to train physicians in clinical ethics.
Throughout the morning, ethics fellows, ethicists, and center associates
engaged in spirited exchanges as they
reviewed classic ethics cases.
Following the case consultations, the
essay finalists presented their essays. The
first Claritás essay contest was in 2008. It
was designed by Mark F. Carr, PhD, former
director of the center, to spark interest in
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ethics across the disciplines. The 2008 contest generated 17 entries; the 2009 contest
generated 21 entries. At the end of each presentation, the authors answered questions
from the audience. The convocation attendees then decided the winners of the contest.
First place went to Mark Warren; second place, to Gregory Lammert; and third
place, to Cordel Anderson. This year, an
undergraduate division was added to the
essay contest. The winner was decided by
the associates of the center and went to a
nursing student, Sidney Irving. A special
thank you goes to Dr. Garry FitzGerald,
who generously donated Alaska Airlines
flight miles for our essayists to enjoy as part

of their winnings.
Lunch was served on the second floor
of the Centennial Complex. The design of
the building provides magnificent views of
the San Bernardino and San Gabriel
mountains from every floor.
Following lunch in the Frank
Damazo Amphitheater, Dr. Branson moderated a roundtable, “God and the
American Health Care System.” Could
health care reform spell disaster for local
hospitals? Are Christian beliefs at stake in
legislation moving through the U.S.
Congress? Do Seventh-day Adventists
have anything at stake? These and other
questions were addressed by members of
the roundtable, including Ruthita Fike,
CEO of the Loma Linda University
Medical Center; Daniel Giang, MD, Loma
Linda University School of Medicine; Joan
Sabaté, MD, PhD, Loma Linda University
School of Public Health; and Nicholas
Kockler, PhD, Loyola Marymount
University, Los Angeles.
The roundtable was open to the
general public and was attended by about
170 people.
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2010 ContriBUtor’S ConVoCation:
etHiCS in tHe inland eMpire
thics is everywhere; that was especially
true in the Inland Empire on Saturday,
November 6, 2010, as the Center for
Christian Bioethics turned its focus on
“Ethics in the Inland Empire” for the 19th
annual Contributor’s Convocation.
Roy Branson, PhD, director of the
Center for Christian Bioethics, opened the
day’s activities with interviews of School of
Religion alumni. Robert Kiger received his
MA in biomedical and clinical ethics in
1985, as well as earning his DDS from
LLU School of Dentistry in 1970. Dr.
Kiger continues to pass the ethics torch to
LLU dental students by teaching many of
the School of Dentistry ethics courses.
The next alumna up was Ruthanne
Williams. Ms. Williams received her master’s in 2002. She is currently a social worker
at Redlands Community Hospital, but prior
to that, Ms. Williams served many years at
Loma Linda as a social worker and as a clinical ethicist. Ms.Williams has been a presenter at the center’s Bioethics Grand Rounds
and at past Contributor’s Convocations.
The morning presentations transitioned from former students to current fellows. Each of the ethics fellows presented
the area he or she has been researching.
Gina Mohr, MD, a family medicine practitioner and director of palliative care, presented “Ethical Issues in Palliative
Sedation.” Tae Kim, MD, is an emergency
medicine physician and leads the fourth
year medical student ethics elective. His
presentation covered “Ethics in Disasters.”
Grace Oei, MD, is an internal medicine
and pediatric physician, as well as a pediatric critical care fellow. Her presentation
was “Ethics of Resource Allocations.” And
finally, Steve Hardin, MD, internal medicine and ethics, has been associated with
the center for years, and when he returned
to California he was quickly recruited for
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the fellows program. His presentation covered his specialty of hematology-oncology,
“Ethical Issues in Oncology.”
To round out the morning presentations, Robert Orr, MD, focused on “The
Endangered Right of Conscience.” In other
words, does a health care professional have
the right to refuse to do a procedure based
on religious beliefs?
The year 2010 featured the third
annual Claritás: Clarity in Ethics Essay
Contest. This essay contest was created to
encourage all full-time students to participate in the ethics discussion by writing on
the topic of the year.
This year’s topic for the essay contest
was“Moral Distress and the Conscience of
the Health Care Professional”—clearly
relating to the final topic of the morning
session on right of conscience. The three
finalists included two medical students and
a psychology student. It was again a difficult decision between first and second
place, but ultimately first place was
awarded to Gregory Lammert. His prize is
a roundtrip ticket anywhere Alaska
Airlines flies within the United States,
Canada, and Mexico. Second place was
awarded to John Park, who will enjoy a
roundtrip ticket anywhere Alaska Airlines

flies within the United States. Both airline
tickets were generously donated by Dr.
Garry FitzGerald. Third place went to
Andrew Wa (LLUSM) and runner-up
went to Ileana Galvin (LLUSPH.)
Dr. Branson started a new tradition
with the 2009 Contributor’s Convocation
by following the event with a roundtable.
This year’s roundtable was based on the
award of a two-year, nearly $1 million
grant to Loma Linda University School of
Public Health to generate data on the
health status of neighborhoods closest to
the one railyard in California (located in
San Bernardino) deemed to present the
highest public health risk by the California
Air Resources Board. It was a lively debate
concerning the moral, health, and public
policy aspects of an immediate environmental hazard. Roundtable participants
included Pat Morris, mayor of San
Bernardino; Susanne Montgomery, PhD,
MPH, Loma Linda University School of
Public Health; Samuel Soret, PhD, Loma
Linda University School of Public Health;
Davis Seep, BNSF Railway; and Tom
Dolan, PhD, Inland Congregations United
for Change (ICUC). The roundtable was
recorded and can be viewed online at
<www.vimeo.com/16841068>.

etHiCS alUMni UpdateS
rian Brock, MA, DPhil, is a 1996
alumnus of the Loma Linda
University School of Religion biomedical and clinical ethics master’s program.
Since his graduation from LLU, he has
earned a DPhil from King’s College,
London.
Dr. Brock is currently a lecturer in
moral and practical
theology at the School
of Divinity, History,
and Philosophy, King’s
College, University of
Aberdeen, Scotland. Practical theology
in Aberdeen, as Dr. Brock describes it,
“begins and ends with inquiries focused
on practices. Our task is to think
through faith not as ‘belief ’ but as lived.”
He finds theology most interesting when
it is “done in relation to the concrete
questions of daily life.” It is not surprising that he has the same practical
approach to Christian ethics.
Dr. Brock has written several books
on Christian ethics:
· Theology, Disability and the New
Genetics: Why Science Needs the
Church (London: T&T Clark,
2007)
· Singing the Ethos of God: On the
Place of Christian Ethics in Scripture,
(Grand Rapids: Eerdmans, 2007)
· Evoking Lament: A Theological
Discussion (London: T&T Clark,
2009)
And in his most recent book,
Christian Ethics in a Technological Age
(Grand Rapids: Eerdmans, 2010), Dr.
Brock develops a theological ethics that
addresses moral
challenges surrounding new
technology.
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atrina Bramstedt, PhD, is a 1998
alumna of the Loma Linda University
School of Religion biomedical and clinical
ethics master’s program. After graduating
from LLU, she moved on to UCLA. In the
School of Medicine, she was an ethics fellow
training in bioethics consultation with a specialty focus in heart transplantation and
research ethics. She moved to Australia and,
in 2002, earned her PhD in community
medicine and general practice, with a
bioethics emphasis, from Monash
University, Victoria, Australia.
Dr. Bramstedt was
formerly on staff at the
Cleveland Clinic, where
she worked in both inpatient and outpatient settings, performing more
than 800 consultations.
She is currently chair of the ethics committee for NATCO (The Organization for
Transplant Professionals.) She also works as
an ethics consultant to the California
Transplant Donor Network (CTDN), a
San Fransisco BayArea non-profit organization dedicated to saving and improving lives
through organ and tissue donation for transplantation. Dr. Bramstedt also serves as an
ethics consultant, living donor advocate, and
philosophical counselor at her own practice
found at AskTheEthicist.com.
Dr. Bramstedt is a prolific writer and
has published more than 75 articles in peerreviewed medical and ethics journals. She
also has a long history of presentations,
teaching, and research.
Dr. Bramstedt co-authored her latest
book with Albert R. Jonsen, PhD, a pioneer
in the field of clinical ethics, Finding Your
Way: A Medical
Ethics Handbook
for Patients and
Families, (NY:
Hilton Publishing,
2011).
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Update online
The center is going green and saving money at the same time! If we can send UPDATE to you via
e-mail rather than snail mail we can save trees and fossil fuels in the publication and transportation of
UPDATE, and we will save money in publication and postage costs.
Just send us an e-mail at bioethics@llu.edu and we will add your name to the electronic mailing list.
No waiting at the mailbox for your next issue.
e-mail your first and last name to bioethics@llu.edu. it’s that simple.
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